NICHI BRITE (AFO-202), one of the NICHI GLUCAN brand products for overseas markets, has undergone clinical trials in Parkinson’s disease patients, and the results will be presented at ASENT 2023 – American Society for Experimental Neurotherapeutics Annual Meeting, March 13-15, 2012.
Every year, April 11 is World Parkinson’s Day, and to commemorate the occasion, on April 10, GN Corporation will co-host a hybrid face-to-face and online “World Parkinson’s Day 2023” seminar in collaboration with KL University (India), Be Well Hospital (India), Map healthcare (UAE), and Nichi-in Center for Regenerative Medicine (India).
In recent years, there is increasing evidence of a strong link between neurodegenerative diseases and the gut microbiota, the “second genome”. This seminar will provide an overview of alpha synuclein-associated neurological diseases and a discussion of new therapeutic approaches with novel beta glucan through gut microbiota control.
